3,790
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway

, , , , , , , , , & show all
Pages 83-89 | Received 14 Sep 2018, Accepted 26 Oct 2018, Published online: 19 Jan 2019

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.